gabapentin

Generic: gabapentin

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

gabapentin 600 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-166
Product ID 31722-166_8796e28d-fb63-4438-bec3-aac2dd9decf5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214957
Listing Expiration 2026-12-31
Marketing Start 2021-10-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722166
Hyphenated Format 31722-166

Supplemental Identifiers

RxCUI
310433 310434
UPC
0331722167017 0331722166058 0331722167055 0331722166010
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA214957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (31722-166-01)
  • 500 TABLET in 1 BOTTLE (31722-166-05)
source: ndc

Packages (2)

Ingredients (1)

gabapentin (600 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8796e28d-fb63-4438-bec3-aac2dd9decf5", "openfda": {"nui": ["N0000008486"], "upc": ["0331722167017", "0331722166058", "0331722167055", "0331722166010"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["9ead7825-d11b-4e00-8533-328d097b8f83"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-166-01)", "package_ndc": "31722-166-01", "marketing_start_date": "20211001"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-166-05)", "package_ndc": "31722-166-05", "marketing_start_date": "20211001"}], "brand_name": "GABAPENTIN", "product_id": "31722-166_8796e28d-fb63-4438-bec3-aac2dd9decf5", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-166", "generic_name": "Gabapentin", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20211001", "listing_expiration_date": "20261231"}